WOOJUNG BIO Inc Capital Reinvestment Ratio

Latest as of March 2025: 0.12x

WOOJUNG BIO Inc capital reinvestment ratio. WOOJUNG BIO Inc (215380) has a Capital Reinvestment Ratio of 0.12x as of March 2025, meaning it reinvests 0% of its operating cash flow (₩1.59 Billion) in capital expenditures (₩191.51 Million). Check how aggressively does WOOJUNG BIO Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.12x
Capex / Operating Cash Flow

Operating Cash Flow

₩1.59 Billion
KRW

Capital Expenditures

₩191.51 Million
KRW

Data as of

Mar 2025
Most recent filing

Capital Reinvestment Ratio of WOOJUNG BIO Inc (2019–2022)

Capital reinvestment ratio of WOOJUNG BIO Inc from 2019 to 2022. This chart tracks WOOJUNG BIO Inc's Capital Reinvestment Ratio across 3 annual periods. Also explore WOOJUNG BIO Inc (215380) net asset momentum to track the company's year-over-year net asset growth rate.

WOOJUNG BIO Inc Capital Reinvestment Ratio by Year (2019–2022)

WOOJUNG BIO Inc capital reinvestment ratio by year from 2019 to 2022. For the full cash flow conversion analysis, see WOOJUNG BIO Inc cash flow conversion.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2022 4.56x ₩2.50 Billion ₩11.42 Billion ▼ -78.5%
2021 21.23x ₩1.73 Billion ₩36.68 Billion ▲ +105.0%
2019 10.36x ₩208.72 Million ₩2.16 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow